Jiangsu Recbio Technology Co., Ltd. (HKG:2179)
Hong Kong · Delayed Price · Currency is HKD 4.300
-0.200 (-4.44%)
Mar 4, 2026, 11:08 AM HKT
Jiangsu Recbio Technology Employees
Jiangsu Recbio Technology had 507 employees as of June 30, 2025. The number of employees decreased by 24 or -4.52% since the number was reported on December 31, 2024.
Employees
507
Change
-24
Growth
-4.52%
Revenue / Employee
62.92K HKD
Profits / Employee
-1.40M HKD
Market Cap
2.65B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 507 | -24 | -4.52% |
| Dec 31, 2024 | 531 | 59 | 12.50% |
| Dec 31, 2023 | 472 | -60 | -11.28% |
| Dec 31, 2022 | 532 | 111 | 26.37% |
| Dec 31, 2021 | 421 | -10 | -2.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1,629 |
| Frontage Holdings | 1,540 |
| AIM Vaccine | 1,493 |
| BioDlink International Company | 604 |
| Qyuns Therapeutics | 337 |
| Zhaoke Ophthalmology | 270 |
| Clover Biopharmaceuticals | 243 |
| TYK Medicines | 163 |